Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors

被引:1
|
作者
Boehm, Kevin [1 ,2 ]
Schulze-Niemand, Eric [1 ]
Kaehne, Thilo [1 ]
Siddiqui, Elisa [1 ]
Taeger, Christian [1 ]
Ramsbeck, Daniel [2 ]
Buchholz, Mirko [2 ]
Naumann, Michael [1 ,3 ,4 ]
机构
[1] Otto Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany
[2] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Drug Design & Target Validat MWT, Bioctr, Halle, Germany
[3] Otto Guericke Univ, Inst Expt Internal Med, Med Fac, Leipziger Str 44, D-39120 Magdeburg, Germany
[4] PerioTrap Pharmaceut GmbH, Bioctr, Halle, Germany
关键词
chemical synthesis; drug design; papain-like protease; ubiquitin-specific proteases; USP2; SMALL-MOLECULE INHIBITOR; UBIQUITIN; SPECIFICITY; DISCOVERY; CELLS;
D O I
10.1002/ardp.202200661
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ubiquitin-specific proteases represent a family of enzymes that catalyze the cleavage of ubiquitin from specific substrate proteins to regulate their activity. USP48 is a rarely studied USP, which has recently been linked to inflammatory signaling via regulation of the transcription factor nuclear factor kappa B. Nonetheless, a crystal structure of USP48 has not yet been resolved and potent inhibitors are not known. We screened a set of 14 commercially available USP inhibitors for their activity against USP48 and identified the USP2 inhibitor "ML364" as a candidate for further optimization. Using a ligand-based approach, we derived and synthesized a series of ML364 analogs. The IC50 concentrations of the new compounds to inhibit USP48 were determined in a deubiquitinylase activity assay by measuring the fluorescence intensity using tetra-ubiquitin rhodamine110 as substrate. A compound containing a carboxylic acid functionalization (17e) inhibited USP48 activity toward tetra-ubiquitin rhodamine110 with an IC50 of 12.6 mu M. Further structure-based refinements are required to improve the inhibition activity and specificity.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Catalytic domain of deubiquitinylase USP48 directs interaction with Rel homology domain of nuclear factor kappaB transcription factor RelA
    Ahmed Ghanem
    Katrin Schweitzer
    Michael Naumann
    Molecular Biology Reports, 2019, 46 : 1369 - 1375
  • [2] Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D
    Whitesitt, CA
    Simon, RL
    Reel, JK
    Sigmund, SK
    Phillips, ML
    Shadle, JK
    Heinz, LJ
    Koppel, GA
    Hunden, DC
    Lifer, SL
    Berry, D
    Ray, J
    Little, SP
    Liu, XD
    Marshall, WS
    Panetta, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) : 2157 - 2162
  • [3] Cysteine derivatives as inhibitors for carboxypeptidase A: Synthesis and structure-activity relationships
    Park, JD
    Kim, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 911 - 918
  • [4] Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors
    Marighetti, Federico
    Steggemann, Kerstin
    Hanl, Markus
    Wiese, Michael
    CHEMMEDCHEM, 2013, 8 (01) : 125 - 135
  • [5] Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors
    Asoh, Kohsuke
    Kohchi, Masami
    Hyoudoh, Ikumi
    Ohtsuka, Tatsuo
    Masubuchi, Miyako
    Kawasaki, Kenichi
    Ebiike, Hirosato
    Shiratori, Yasuhiko
    Fukami, Takaaki A.
    Kondoh, Osamu
    Tsukaguchi, Toshiyuki
    Ishii, Nobuya
    Aoki, Yuko
    Shimma, Nobuo
    Sakaitani, Masahiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1753 - 1757
  • [6] Design, synthesis and structure-activity relationships of novel ALS inhibitors
    Ren, TR
    Yang, HW
    Gao, X
    Yang, XL
    Zhou, JJ
    Cheng, FH
    PEST MANAGEMENT SCIENCE, 2000, 56 (03) : 218 - 226
  • [7] Structure-Activity Relationship of USP5 Inhibitors
    Mann, Mandeep K.
    Zepeda-Velazquez, Carlos A.
    Gonzalez-Alvarez, Hector
    Dong, Aiping
    Kiyota, Taira
    Aman, Ahmed M.
    Loppnau, Peter
    Li, Yanjun
    Wilson, Brian
    Arrowsmith, Cheryl H.
    Al-Awar, Rima
    Harding, Rachel J.
    Schapira, Matthieu
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15017 - 15036
  • [8] Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships
    Khan, Khalid Mohammed
    Mughal, Uzma Rasool
    Khan, Mahmud Tareq Hassan
    Zia-Ullah
    Perveen, Shahnaz
    Choudhary, Muhammad Iqbal
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 6027 - 6033
  • [9] Catalytic domain of deubiquitinylase USP48 directs interaction with Rel homology domain of nuclear factor kappaB transcription factor RelA
    Ghanem, Ahmed
    Schweitzer, Katrin
    Naumann, Michael
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (01) : 1369 - 1375
  • [10] Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD
    Strancar, K
    Blanot, D
    Gobec, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 343 - 348